Frank Takkinen
Stock Analyst at Lake Street
(0.99)
# 3,938
Out of 5,134 analysts
74
Total ratings
28.79%
Success rate
-15.32%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.29 | +413.70% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.30 | -18.60% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $13.97 | +186.33% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.67 | +71.31% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $5.37 | +123.57% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $34.64 | +15.47% | 2 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.98 | +310.26% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $0.77 | +291.80% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.49 | +168.46% | 3 | Oct 28, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $1.15 | +421.74% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $2 | $1.10 | +81.82% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $60.39 | +148.39% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $11.26 | +113.14% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $4.74 | +195.36% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.66 | +28.64% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $14.30 | +81.82% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $13.58 | +120.91% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.63 | +255.24% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.74 | +187.36% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $36.50 | -17.81% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.69 | +770.95% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.08 | +92.31% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $15.48 | -22.48% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.84 | +134.38% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.66 | +243.35% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $10.27 | +2,596.20% | 2 | Jan 18, 2023 |
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.29
Upside: +413.70%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.30
Upside: -18.60%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $13.97
Upside: +186.33%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.67
Upside: +71.31%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $5.37
Upside: +123.57%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $34.64
Upside: +15.47%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.98
Upside: +310.26%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.77
Upside: +291.80%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.49
Upside: +168.46%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.15
Upside: +421.74%
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.10
Upside: +81.82%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $60.39
Upside: +148.39%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $11.26
Upside: +113.14%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $4.74
Upside: +195.36%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.66
Upside: +28.64%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $14.30
Upside: +81.82%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $13.58
Upside: +120.91%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.63
Upside: +255.24%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.74
Upside: +187.36%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $36.50
Upside: -17.81%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.69
Upside: +770.95%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.08
Upside: +92.31%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $15.48
Upside: -22.48%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.84
Upside: +134.38%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.66
Upside: +243.35%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $10.27
Upside: +2,596.20%